| Primary |
| Anaesthesia |
26.8% |
| Procoagulant Therapy |
14.6% |
| Prophylaxis |
7.3% |
| Thrombosis Prophylaxis |
7.3% |
| Menorrhagia |
6.1% |
| Surgery |
6.1% |
| Haemorrhage |
4.9% |
| Knee Arthroplasty |
3.7% |
| Blood Pressure |
2.4% |
| Deep Vein Thrombosis |
2.4% |
| Hypertension |
2.4% |
| Hypothyroidism |
2.4% |
| Peptic Ulcer Haemorrhage |
2.4% |
| Pulmonary Haemorrhage |
2.4% |
| Respiratory Tract Infection |
2.4% |
| Bleeding Menstrual Heavy |
1.2% |
| Blood Cholesterol |
1.2% |
| Depression |
1.2% |
| Diabetes Mellitus |
1.2% |
| Epistaxis |
1.2% |
|
| Pulmonary Embolism |
29.8% |
| Convulsion |
19.1% |
| Cerebral Infarction |
4.3% |
| Death |
4.3% |
| Mesenteric Occlusion |
4.3% |
| Pharyngeal Oedema |
4.3% |
| Product Quality Issue |
4.3% |
| Thrombosis |
4.3% |
| Acute Myocardial Infarction |
2.1% |
| Anaphylactic Reaction |
2.1% |
| Cardiomyopathy |
2.1% |
| Cerebrovascular Accident |
2.1% |
| Chemical Burns Of Eye |
2.1% |
| Drug Administration Error |
2.1% |
| Dysphagia |
2.1% |
| Encephalocele |
2.1% |
| Gastrointestinal Haemorrhage |
2.1% |
| Grand Mal Convulsion |
2.1% |
| Haemorrhage |
2.1% |
| Headache |
2.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.8% |
| Haemorrhage |
12.8% |
| Infection |
8.5% |
| Factor Viii Deficiency |
6.4% |
| Gastrointestinal Haemorrhage |
6.4% |
| Hiv Infection |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Prophylaxis |
4.3% |
| Psychotic Disorder |
4.3% |
| Respiratory Tract Infection |
4.3% |
| Surgery |
4.3% |
| Thrombosis Prophylaxis |
4.3% |
| Anxiety |
2.1% |
| Neuropathy Peripheral |
2.1% |
| Sleep Disorder |
2.1% |
|
| Cerebral Ischaemia |
18.8% |
| Haemorrhage |
18.8% |
| Pulmonary Embolism |
12.5% |
| Sudden Death |
12.5% |
| Cerebral Infarction |
6.3% |
| Convulsion |
6.3% |
| Death |
6.3% |
| Grand Mal Convulsion |
6.3% |
| Vertigo |
6.3% |
| Vision Blurred |
6.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.3% |
| Drug Use For Unknown Indication |
17.2% |
| Prophylaxis |
15.0% |
| Hypertension |
3.5% |
| Breast Cancer |
3.2% |
| Myelodysplastic Syndrome |
2.9% |
| Acute Myeloid Leukaemia |
2.4% |
| Lymphadenopathy |
2.1% |
| Musculoskeletal Pain |
2.1% |
| Idiopathic Thrombocytopenic Purpura |
1.9% |
| Pain |
1.6% |
| Von Willebrand's Disease |
1.6% |
| Nausea |
1.3% |
| Hereditary Angioedema |
1.1% |
| Menorrhagia |
1.1% |
| Prophylaxis Of Nausea And Vomiting |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Disseminated Intravascular Coagulation |
0.8% |
| Haemorrhage |
0.8% |
| Sedation |
0.8% |
|
| Lymphadenopathy |
8.7% |
| Respiratory Failure |
8.7% |
| Vomiting |
8.7% |
| Oedema Peripheral |
6.5% |
| Red Blood Cell Count Decreased |
6.5% |
| Shock |
6.5% |
| Thrombocytopenia |
6.5% |
| Acute Myeloid Leukaemia |
4.3% |
| Coagulation Factor Increased |
4.3% |
| Dyspnoea |
4.3% |
| Hearing Impaired |
4.3% |
| Hepatic Enzyme Increased |
4.3% |
| Hyperammonaemic Encephalopathy |
4.3% |
| Pyrexia |
4.3% |
| Uterine Leiomyoma |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Bacterial Infection |
2.2% |
| Blood Bilirubin Increased |
2.2% |
| Brain Oedema |
2.2% |
| Cardiopulmonary Failure |
2.2% |
|
